
Do Quality Improvement Initiatives Improve Outcomes for Patients in Antiretroviral Programs in Low- and Middle-Income Countries? A Systematic Review
Author(s) -
Sally Hargreaves,
Kieran Rustage,
Laura B Nellums,
Joshua Bardfield,
Bruce Agins,
Pierre Barker,
M Rashad Massoud,
Nathan Ford,
Meg Doherty,
Gillian Dougherty,
Satvinder Singh
Publication year - 2019
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0000000000002085
Subject(s) - medicine , psychological intervention , interquartile range , medline , quality assurance , antiretroviral therapy , low and middle income countries , developing country , family medicine , quality management , viral load , environmental health , human immunodeficiency virus (hiv) , nursing , management system , external quality assessment , management , pathology , political science , law , economics , economic growth
There have been a range of quality improvement (QI) and quality assurance initiatives in low- and middle-income countries to improve antiretroviral therapy (ART) treatment outcomes for people living with HIV. To date, these initiatives have not been systematically assessed and little is known about how effective, cost-effective, or sustainable these strategies are in improving clinical outcomes.